Leveraging glypican-3 (GPC3)-mediated lysosome-targeting chimeras (GLTACs) for targeted membrane protein degradation DOI Creative Commons
Bin Yu

Acta Pharmaceutica Sinica B, Journal Year: 2025, Volume and Issue: 15(4), P. 2293 - 2294

Published: April 1, 2025

Language: Английский

Leveraging glypican-3 (GPC3)-mediated lysosome-targeting chimeras (GLTACs) for targeted membrane protein degradation DOI Creative Commons
Bin Yu

Acta Pharmaceutica Sinica B, Journal Year: 2025, Volume and Issue: 15(4), P. 2293 - 2294

Published: April 1, 2025

Language: Английский

Citations

0